Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Cardiovascular Research Institute Established at Weill Cornell Medicine

 With the goal of improving heart health for patients worldwide, Weill Cornell Medicine has established the Cardiovascular Research Institute to expand and enhance the institution's basic and translational research activities. Dr. Geoffrey Pitt, a leading cardiologist and scientist, will direct the institute, which will be dedicated to understanding the molecular, cellular and genetic underpinnings of the disease.

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

The purpose of this study is to better understand the changes in cholesterol levels, the blood vessels, and overall health of children and adults with homozygous familial hypercholesterolemia (hoFH).

Homozygous familial hypercholesterolemia is a rare (~1 in 1,000,000) inherited (genetic) disorder that is usually due to a double mutation in the gene for the Low Density Lipoprotein (LDL) receptor.

Autosomal Dominant Polycystic Kidney Disease Data Repository

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, affecting more than 500,000 people in the U.S. and 10 million people worldwide. ADPKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all ADPKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even among members of the same family.

What Inspires Giving? Meet Dr. John Leonard

During his twenty-five years at Weill Cornell Medicine, Dr. John Leonard, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, has been motivated by the same driving force: delivering the best possible treatments and cures to his patients. Moved by this incredible devotion and commitment, hundreds of Dr.

NewYork-Presbyterian, Weill Cornell Medicine and Columbia University College of Physicians and Surgeons Join Launch of SPARK, Nation's Largest Autism Research Study

NewYork-Presbyterian, Weill Cornell Medicine and Columbia University College of Physicians and Surgeons have helped launch the Simons Foundation Powering Autism Research for Knowledge (SPARK), an online research initiative designed to become the largest autism study ever undertaken in the United States.

Interim Dean to Lead Weill Cornell Medicine Beginning June 1

The Cornell University Board of Trustees and the Weill Cornell Medicine Board of Overseers have approved the appointment of physician-scientist Dr. Augustine M.K. Choi, the Sanford I. Weill Chairman of the Weill Department of Medicine, as interim dean of Weill Cornell Medicine and interim provost for medical affairs of Cornell University, starting June 1.

Jill Roberts Institute for Research in Inflammatory Bowel Disease Leads the Field

A string of high-profile research studies underscores the early successes of the Jill Roberts Institute for Research in Inflammatory Bowel Disease, where scientists are assiduously investigating the root causes of the disease. Now, with the official opening of its permanent laboratories, the Weill Cornell Medicine institute is poised to lead the way in advancing research to improve patient care.

Weill Cornell Lymphoma Program Study on Mantle Cell Lymphoma Has Received a Top 10 Clinical Research Forum Achievement Award from a National Clinical Research Organization

Careers

The Weill Cornell Medicine/NewYork-Presbyterian Joint Clinical Trials Office (JCTO) is a centralized research administration resource providing comprehensive support for clinical trials to principal investigators and their teams in the following service areas:

JCTO roles

Excessive Iron in the Lung Implicated in COPD

Excessive iron buildup in the lungs could be a major cause of chronic obstructive pulmonary disease, Weill Cornell Medicine scientists find in a new study. The investigators also believe that they have identified the culprit for the excess: A gene they previously found to increase patients' susceptibility to the progressive lung disease.